-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, O9jEVdxU8biAmda1qxhRQJu98wrWnxJYBoljBpYCAKWObM6Vkw4UlzZj+koNnWyb VEgRHBlSHE83VQi48dF3fA== 0000950133-09-000294.txt : 20090211 0000950133-09-000294.hdr.sgml : 20090211 20090211170655 ACCESSION NUMBER: 0000950133-09-000294 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20081231 FILED AS OF DATE: 20090211 DATE AS OF CHANGE: 20090211 EFFECTIVENESS DATE: 20090211 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BB BIOTECH AG CENTRAL INDEX KEY: 0000924223 STATE OF INCORPORATION: V8 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-06964 FILM NUMBER: 09590553 BUSINESS ADDRESS: STREET 1: VODERGASSE 3 STREET 2: SWITZERLAND CITY: SCHAFFHAUSEN STATE: V8 ZIP: CH-8300 BUSINESS PHONE: 411724 59 59 MAIL ADDRESS: STREET 1: VODERGASSE 3 STREET 2: SWITZERLAND CITY: SCHAFFHAUSEN STATE: V8 ZIP: CH-8300 13F-HR 1 w7268603e13fvhr.txt 13F-HR UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 13F Form 13F COVER PAGE Report for Calendar Year or Quarter Ended: December 31, 2008 Check here if Amendment [ ]; Amendment Number: __________ This Amendment (Check only one.): [ ] is a restatement. [ ] adds new holdings entries. Institutional Investment Manager Filing this Report: Name: BB Biotech AG Address: Vordergasse 3 Schaffhausen Switzerland CH-8200 Form 13F File Number: 28-6964 The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: Michael Hutter Title: SIGNING AUTHORITY Phone: 41 (44) 267 67 00 Signature, Place, and Date of Signing: /s/ Michael Hutter - ------------------------------------- Schaffhausen, Switzerland, February 6, 2009 Report Type (Check only one.): [X] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.) [ ] 13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).) [ ] 13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).) 1 Form 13F SUMMARY PAGE Report Summary: Number of Other Included Managers: 3 Form 13F Information Table Entry Total: 14 Form 13F Information Table Value Total: $942,017 (thousands) List of Other Included Managers: Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report. No. Form 13F File Number Name 1 28-11193 Biotech Focus N.V. 2 28-11191 Biotech Invest N.V. 3 28-11189 Biotech Target N.V. 2 BB BIOTECH AG FORM 13F INFORMATION TABLE
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8 -------------- -------- --------- -------- ------------------ ---------- -------- --------------------- TITLE OF VALUE SHS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY NAME OF ISSUER CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGERS SOLE SHARED NONE -------------- -------- --------- -------- --------- --- ---- ---------- -------- --------- ------ ---- Affymetrix Inc COM 00826T108 5,980 2,000,000 SH DEFINED 1 2,000,000 NONE NONE Arena Pharmaceuticals Inc COM 040047102 13,925 3,339,430 SH DEFINED 3 3,339,430 NONE NONE Biogen Idec Inc COM 09062X103 81,504 1,711,200 SH DEFINED 1 1,711,200 NONE NONE Celgene Corp COM 151020104 241,266 4,364,439 SH DEFINED 2 4,364,439 NONE NONE Elan Corp ADR 284131208 9,000 1,500,000 SH DEFINED 2 1,500,000 NONE NONE Genentech Inc COM NEW 368710406 91,569 1,104,436 SH DEFINED 1 1,104,436 NONE NONE Gilead Sciences Inc COM 375558103 307,025 6,003,618 SH DEFINED 1 6,003,618 NONE NONE Incyte Corp COM 45337C102 3,590 947,166 SH DEFINED 3 947,166 NONE NONE Keryx Biopharmaceuticals Inc COM 492515101 207 939,311 SH DEFINED 3 939,311 NONE NONE Medicines Co COM 584688105 8,648 587,100 SH DEFINED 3 587,100 NONE NONE Optimer Pharmaceuticals Inc COM 68401H104 12,443 1,027,539 SH DEFINED 3 1,027,539 NONE NONE Rigel Pharmaceuticals Inc COM NEW 766559603 2,960 370,000 SH DEFINED 3 370,000 NONE NONE Vertex Pharmaceuticals Inc COM 92532F100 151,900 5,000,000 SH DEFINED 3 5,000,000 NONE NONE Zymogenetics Inc COM 98985T109 12,000 4,000,000 SH DEFINED 3 4,000,000 NONE NONE
3 -----END PRIVACY-ENHANCED MESSAGE-----